On Methylphenidate and Sleep: A Two-Year Study

In this episode, we explore the cardiac and metabolic safety profile of antipsychotics in youth, based on a World Health Organization Safety Database analysis. We discuss age-dependent risks, specific medication concerns, and the importance of monitoring. How can clinicians balance the benefits of antipsychotics with potential cardiometabolic risks in young patients? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 20 Cardiac and Metabolic Safety Profile of Antipsychotics in Youth

In this episode, we explore the unexpected consequences of promoting a purely biological view of mental illness. How does framing mental health conditions as solely biological affect stigma, patient outcomes, and physician empathy? We delve into the complex interplay between biological and psychosocial factors in mental health treatment. Faculty: David Mintz, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1 CME: Psychodynamic Psychopharmacology: Alliance, Communication, and Psychotherapy Skills The Biological Theory of Illness and Stigma

In this episode, we explore the bidirectional relationship between psychiatric disorders and cardiovascular disease, discussing a groundbreaking study involving over 900,000 subjects. We ask: Can a mental health diagnosis increase your risk of heart disease? Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D. Learn more about our membership her Earn 0.5 CMEs: Quick Take Vol. 60 Psychiatric Disorders and Subsequent Risk of Cardiovascular Disease

In this episode, we explore the science behind the art of psychopharmacotherapy with Dr. David Mintz. We delve into how psychosocial factors, including the prescriber's approach, can significantly impact medication outcomes. Did you know that some psychiatrists achieve better results with placebos than others do with active medications? Faculty: David Mintz, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1 CME: Psychodynamic Psychopharmacology: Alliance, Communication, and Psychotherapy Skills The Science of the Art of Psychopharmacotherapy

In this episode, we explore the long-term effects of methylphenidate on sleep in children and adolescents with ADHD. Can stimulant medication actually improve sleep in ADHD patients? We dive into surprising research findings that challenge common assumptions about ADHD treatment and sleep disturbances. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 20 Long-Term Effects of Methylphenidate on Sleep in Children and Adolescents With ADHD

In this episode, we explore the strategic use of natural medications in psychiatry, focusing on combination therapies for various mental health conditions. Dr. David Mischoulon discusses potential synergies between natural remedies and conventional drugs, as well as all-natural combinations. But how do we balance efficacy with safety when using these less-studied treatments? Faculty: David Mischoulon, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Natural Medication in Psychiatry: Focus on Versatile Agents and Combination Strategies Potential Combinations of Natural Medication for Psychiatric Disorders

In this episode, we explore the use of memantine in treating trichotillomania and skin picking disorder. Could this common Alzheimer's medication be the breakthrough we've been waiting for in managing body-focused repetitive behaviors? Dr. Bob Hudak discusses a promising study that offers new hope for patients struggling with these often-overlooked conditions. Faculty: Robert Hudak, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 60 Efficacy of Memantine in Treating Trichotillomania and Skin-Picking Disorder

In this episode, we explore Ashwagandha, a versatile natural remedy in psychiatry. We discuss its potential applications in treating anxiety, depression, OCD, and other mental health disorders. Could this ancient herb be the key to managing treatment-resistant patients? Faculty: David Mischoulon, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Natural Medication in Psychiatry: Focus on Versatile Agents and Combination Strategies Ashwagandha (ASW): Potential Indications and Administration in Psychiatric Disorders

In this episode, we explore the controversial use of electroconvulsive therapy (ECT) in adolescents with severe depression and suicidality. We discuss a study examining ECT's effectiveness, factors influencing outcomes, and its potential as a treatment option. Is ECT a viable last resort for treatment-resistant depression in teens? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 19 Electroconvulsive Therapy for Adolescents With Severe Depression and Suicidality

In this episode, we explore the potential uses of Cannabidiol (CBD) in psychiatric practice. We discuss its mechanisms, evidence for various disorders, and guidelines for safe use. Is CBD the next breakthrough in mental health treatment, or just another passing trend? Faculty: David Mischoulon, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Natural Medication in Psychiatry: Focus on Versatile Agents and Combination Strategies Cannabidiol: Evidence for Psychiatric Disorders and Recommendations for Using It